Complications after colorectal anastomosis in a patient with metastatic rectal cancer treated with systemic chemotherapy and bevacizumab

Can J Surg. 2008 Jun;51(3):E52-3.

Authors

Amine Akkouche¹, Lucas Sidéris, Guy Leblanc, Yves-E Leclerc, Petro Vafiadis, Pierre Dubé

Affiliation

¹ Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montréal, Que.

PMID: 18682755
PMCID: PMC2496595

No abstract available

MeSH terms

Anastomosis, Surgical
Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bevacizumab
Colon / surgery
Combined Modality Therapy
Contraindications
Digestive System Surgical Procedures
Humans
Laparotomy
Liver Neoplasms / secondary
Male
Middle Aged
Rectal Neoplasms / drug therapy*
Rectal Neoplasms / pathology
Rectal Neoplasms / surgery
Rectum / surgery
Time Factors

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab